Evaluation of cervical cytology.
作者信息
McCrory D C, Matchar D B, Bastian L, Datta S, Hasselblad V, Hickey J, Myers E, Nanda K
出版信息
Evid Rep Technol Assess (Summ). 1999 Jan(5):1-6.
Abstract
摘要
相似文献
1
Evaluation of cervical cytology.宫颈细胞学评估
Evid Rep Technol Assess (Summ). 1999 Jan(5):1-6.
2
Does cervical cancer screening do more harm than good?
Nurs Times. 2001;97(29):20.
3
Liquid-based cytology in cervical screening: a rapid and systematic review.宫颈筛查中的液基细胞学检查：一项快速系统评价
Health Technol Assess. 2000;4(18):1-73.
4
Re: Liquid-based cytology for cervical screening.
Aust N Z J Obstet Gynaecol. 2006 Feb;46(1):70-1; author reply 71-2. doi: 10.1111/j.1479-828X.2006.00528.x.
5
Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening.
Obstet Gynecol. 2000 Nov;96(5 Pt 1):645-52. doi: 10.1016/s0029-7844(00)00979-0.
6
Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.细胞学技术进展的成本与效益评估。国际细胞学学会特别工作组总结。《迈向21世纪的诊断细胞学：一次国际专家会议与教程》
Acta Cytol. 1998 Jan-Feb;42(1):69-75. doi: 10.1159/000331536.
7
Improving the sensitivity of cervical cytology: what are the issues?
Am J Manag Care. 2000 Jul;6(7):838-40.
8
[A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
Lakartidningen. 2000 Sep 13;97(37):4042.
9
[Cervical cancer screening. False negative smears].[宫颈癌筛查。涂片检查假阴性]
Rev Med Suisse Romande. 1997 Aug;117(8):597-601.
10
[Plea for quality cytological specimens in the screening of cervical cancer].
Rev Fr Gynecol Obstet. 1993 Jun;88(6):365-7.
引用本文的文献
1
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.邮寄自采样 HPV 检测试剂盒以改善安全网卫生系统中的宫颈癌筛查：一项混合有效性-实施随机对照试验的方案。
Trials. 2020 Oct 21;21(1):872. doi: 10.1186/s13063-020-04790-5.
2
The potential of RNA as a target for national screening of pre-cancer.RNA作为全国性癌症前期筛查靶点的潜力。
J Public Health Afr. 2018 Dec 21;9(3):866. doi: 10.4081/jphia.2018.866.
3
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.德国两项连续筛查轮次、间隔 6 年的研究中，基于 RNA 的 Aptima 人乳头瘤病毒（AHPV）检测与基于 DNA 的杂交捕获 2 型 HPV 检测的纵向临床性能比较。
J Clin Microbiol. 2019 Jan 2;57(1). doi: 10.1128/JCM.01177-18. Print 2019 Jan.
4
Cervicouterine Cancer Screening - TruScreen™ vs. Conventional Cytology: Pilot Study.宫颈子宫癌筛查——TruScreen™与传统细胞学检查：初步研究
J Cytol. 2018 Jul-Sep;35(3):143-148. doi: 10.4103/JOC.JOC_111_17.
5
Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening.简单但非简易：宫颈癌筛查经济评估马尔可夫模型的系统评价
Clinics (Sao Paulo). 2018 Jul 10;73:e385. doi: 10.6061/clinics/2018/e385.
6
Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.基于社区的 HPV 自我采集与乌干达醋酸视觉检查的比较：ASPIRE 试验的成本效益分析。
BMJ Open. 2018 Jun 12;8(6):e020484. doi: 10.1136/bmjopen-2017-020484.
7
Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.宫颈癌管理中的成本与资源利用：一项真实世界回顾性成本分析
Curr Oncol. 2016 Feb;23(Suppl 1):S14-22. doi: 10.3747/co.23.2914. Epub 2016 Feb 29.
8
Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer.宫颈癌前病变管理中“即诊即治”策略的过度治疗与成本效益
Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):807-14. doi: 10.1158/1055-9965.EPI-15-1044. Epub 2016 Feb 29.
9
Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.针锋相对：25岁以上女性的宫颈癌筛查应通过人乳头瘤病毒（HPV）初筛、基因分型及必要时的细胞学检查来进行。
J Clin Microbiol. 2015 Sep;53(9):2798-804. doi: 10.1128/JCM.01087-15. Epub 2015 May 6.
10
Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.DNA倍体分析与液基细胞学用于宫颈癌筛查的经济学评价
Br J Cancer. 2015 Jun 9;112(12):1951-7. doi: 10.1038/bjc.2015.95. Epub 2015 Apr 28.
Zotero 插件